{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:41:48Z","timestamp":1791520908557,"version":"4.3.4"},"reference-count":48,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Membranous nephropathy (MN) is the most prevalent cause of nephrotic syndrome amongst the non-diabetic adult population. A fifth of idiopathic nephrotic syndrome cases can be attributed to MN, rising to more than 40% in older patients over 60 years. Most MN cases are classified as being of a primary cause, where there is absence of a secondary disease process explaining its manifestation. Traditionally, the standard approach of diagnosing MN involves performing a kidney biopsy as histological evaluation offers not only conclusive evidence of the diagnosis but also provides valuable information regarding disease chronicity and the presence of any other kidney histopathological features. Nevertheless, kidney biopsy is an invasive procedure which poses risks for the patient including bleeding and pain and bears greater costs for the health system. The identification of the phospholipase A2 receptor (PLA2R) antigen in 2009 was a landmark discovery, one which has evolved our understanding of the disease processes in MN and subsequently our management approach of this condition. Antibodies against PLA2R (PLA2RAb) have since emerged as an attractive non-invasive test option to be applied for the diagnosis and prognostication of primary MN. However, much debate and unknowns remain about the accuracy and reliability of testing for PLA2RAb across various primary MN scenarios. We provide a review summarizing the historical journey of PLA2R in relation to its significance in primary MN and, more importantly, evidence emerging over the years which contemplated the role of PLA2RAb as a diagnostic and prognostic tool in primary MN.<\/jats:p>","DOI":"10.3390\/genes14071343","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T01:42:02Z","timestamp":1687830122000},"page":"1343","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The Role of PLA2R in Primary Membranous Nephropathy: Do We Still Need a Kidney Biopsy?"],"prefix":"10.3390","volume":"14","author":[{"given":"Thomas","family":"McDonnell","sequence":"first","affiliation":[{"name":"Department of Renal Medicine, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4561-0844","authenticated-orcid":false,"given":"Henry H. L.","family":"Wu","sequence":"additional","affiliation":[{"name":"Renal Research Laboratory, Kolling Institute of Medical Research, Royal North Shore Hospital, The University of Sydney, Sydney, NSW 2065, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smeeta","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UK"},{"name":"Faculty of Biology, Medicine & Health, The University of Manchester, Manchester M1 7HR, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Chinnadurai","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Northern Care Alliance NHS Foundation Trust, Salford M6 8HD, UK"},{"name":"Faculty of Biology, Medicine & Health, The University of Manchester, Manchester M1 7HR, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMe1906666","article-title":"A First Step toward a New Approach to Treating Membranous Nephropathy","volume":"381","author":"Ruggenenti","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/postgradmedj-2018-135729","article-title":"Primary membranous nephropathy: Comprehensive review and historical perspective","volume":"95","author":"Keri","year":"2019","journal-title":"Postgrad. Med. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/S0140-6736(15)60731-0","article-title":"Pathophysiological advances in membranous nephropathy: Time for a shift in patient\u2019s care","volume":"385","author":"Ronco","year":"2015","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_5","first-page":"313","article-title":"Nephrotic glomerulonephritis","volume":"33","author":"Jones","year":"1957","journal-title":"Am. J. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3181\/00379727-100-24736","article-title":"Production of Nephrotic Syndrome in Rats by Freund\u2019s Adjuvants and Rat Kidney Suspensions","volume":"100","author":"Heymann","year":"1959","journal-title":"Exp. Biol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa012895","article-title":"Antenatal Membranous Glomerulonephritis Due to Anti\u2013Neutral Endopeptidase Antibodies","volume":"346","author":"Debiec","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0165-6147(99)01300-0","article-title":"Receptors for a growing family of secreted phospholipases A2","volume":"20","author":"Lambeau","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2014050502","article-title":"Identification of a Major Epitope Recognized by PLA2R Autoantibodies in Primary Membranous Nephropathy","volume":"26","author":"Fresquet","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_10","first-page":"57","article-title":"Distribution of IgG subclasses in membranous nephropathy","volume":"58","author":"Doi","year":"1984","journal-title":"Clin. Exp. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.kint.2019.10.022","article-title":"A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients","volume":"97","author":"Tomas","year":"2020","journal-title":"Kidney Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2215\/CJN.07210810","article-title":"Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy","volume":"6","author":"Hofstra","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy","volume":"23","author":"Hofstra","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1681\/ASN.2016040449","article-title":"Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up","volume":"28","author":"Dahan","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_17","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021). KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int., 100, S1\u2013S276."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","article-title":"Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy","volume":"97","author":"Sethi","year":"2020","journal-title":"Kidney Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.kint.2020.07.039","article-title":"NELL1 is a target antigen in malignancy-associated membranous nephropathy","volume":"99","author":"Caza","year":"2021","journal-title":"Kidney Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2016010050","article-title":"An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain\u2013Containing 7A\u2013Specific Antibodies in Membranous Nephropathy","volume":"28","author":"Hoxha","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1053\/j.ajkd.2020.04.013","article-title":"Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study","volume":"76","author":"Hanset","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1681\/ASN.2018080852","article-title":"Exostosin 1\/Exostosin 2\u2013Associated Membranous Nephropathy","volume":"30","author":"Sethi","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1681\/ASN.2020081165","article-title":"Protocadherin 7\u2013Associated Membranous Nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.kint.2020.05.030","article-title":"Semaphorin 3B\u2013associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients","volume":"98","author":"Sethi","year":"2020","journal-title":"Kidney Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1681\/ASN.2020101395","article-title":"Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy","volume":"32","author":"Caza","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(04)17142-0","article-title":"Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies","volume":"364","author":"Debiec","year":"2004","journal-title":"Lancet."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Du, Y., Li, J., He, F., Lv, Y., Liu, W., Wu, P., Huang, J., Wei, S., and Gao, H. (2014). The Diagnosis Accuracy of PLA2R-AB in the Diagnosis of Idiopathic Membranous Nephropathy: A Meta-Analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104936"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0002-9343(79)90486-8","article-title":"Long-term prognosis of idiopathic membranous glomerulonephritis","volume":"66","author":"Noel","year":"1979","journal-title":"Am. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2215\/CJN.04710420","article-title":"Systematic Review and Meta-Analysis of Native Kidney Biopsy Complications","volume":"15","author":"Poggio","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000504544","article-title":"Risk Factors Associated with Major Complications after Ultrasound-Guided Percutaneous Renal Biopsy of Native Kidneys","volume":"45","author":"Pombas","year":"2020","journal-title":"Kidney Blood Press. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ekir.2020.01.012","article-title":"Bleeding Complications After Percutaneous Native Kidney Biopsy: Results From the Boston Kidney Biopsy Cohort","volume":"5","author":"Palsson","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ragy, O., Rautemaa, V., Smith, A., Brenchley, P., Kanigicherla, D., and Hamilton, P. (2023). Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0281726"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"890","DOI":"10.34067\/KID.0003262020","article-title":"Kidney Biopsy Is Required for Nephrotic Syndrome with PLA2R+ and Normal Kidney Function: The Con View","volume":"1","author":"Bobart","year":"2020","journal-title":"Kidney360"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/ndt\/gfs439","article-title":"Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy","volume":"28","author":"Svobodova","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.kint.2018.10.021","article-title":"Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies","volume":"95","author":"Bobart","year":"2019","journal-title":"Kidney Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/sj.ki.5000289","article-title":"Renal pathology in idiopathic membranous nephropathy: A new perspective","volume":"69","author":"Troyanov","year":"2006","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41379-019-0267-z","article-title":"Diagnostic role of renal biopsy in PLA2R1-antibody-positive patients with nephrotic syndrome","volume":"32","author":"Wiech","year":"2019","journal-title":"Modern Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2215\/CJN.05480421","article-title":"Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy A Validation Study","volume":"16","author":"Bobart","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2215\/CJN.02510213","article-title":"The Modern Spectrum of Renal Biopsy Findings in Patients with Diabetes","volume":"8","author":"Sharma","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/ki.2015.34","article-title":"Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: Seroconversion after prolonged follow-up","volume":"87","author":"Hofstra","year":"2015","journal-title":"Kidney Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.kint.2022.09.011","article-title":"False positivity for PLA2R1 antibody measured by ELISA in a nephrotic patient with no membranous nephropathy","volume":"103","author":"Hoxha","year":"2023","journal-title":"Kidney Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.kint.2022.11.004","article-title":"False-positive anti-PLA2R ELISA testing in patients with diabetes mellitus","volume":"103","author":"Caza","year":"2023","journal-title":"Kidney Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000431331","article-title":"Renal Phospholipase A2 Receptor in Hepatitis B Virus-Associated Membranous Nephropathy","volume":"41","author":"Xie","year":"2015","journal-title":"Am. J. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ckj\/sfz036","article-title":"The investigative burden of membranous nephropathy in the UK","volume":"13","author":"Hamilton","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/ndt\/gfaa142.P0382","article-title":"P0382 \u201cFalse\u201d Positivity of Serum Anti-Phospholipase A2 Receptor Antibody (Anti-Pla2r Ab) in Patients with Non Membranous Glomerular Disease","volume":"35","author":"Mok","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2215\/CJN.09000819","article-title":"Screening for Cancer in Patients with Glomerular Diseases","volume":"15","author":"Plaisier","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/7\/1343\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:00:55Z","timestamp":1760126455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/7\/1343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["genes14071343"],"URL":"https:\/\/doi.org\/10.3390\/genes14071343","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]}}}